Oxford Expression Technologies is a biotechnology company specialising in recombinant protein expression using baculovirus-based systems. Emerging from a collaboration between Oxford Brookes University and the Natural Environment Research Council, the company provides products, services and scientific expertise for protein production in insect, mammalian and bacterial expression platforms. Its proprietary flashBAC™ technology enables the rapid generation of recombinant baculoviruses for protein expression workflows. These systems support the production of complex proteins, including membrane proteins, glycoproteins and virus-like particles (VLPs). Applications span virology, vaccine research, diagnostics, gene therapy development and biopharmaceutical research.
Oxford Expression Technologies’ portfolio includes the flashBAC™ expression platform, baculovirus transfer vectors, transfection reagents, virus titration kits, insect cell lines and insect cell culture media. The company also supports workflows ranging from gene cloning and vector design to protein expression, virus generation and purified protein production. Its technologies help researchers optimise recombinant protein yield and characterise challenging biological targets. In addition to research products, They also provide specialist services for protein expression projects and pre-GMP process development,
Europa Biosite subsidiaries distribute Oxford Expression Technologies products in Denmark, Estonia, Finland, Iceland, Latvia, Lithuania, Luxembourg, Netherlands, Norway, Sweden and Switzerland.
